Alison Koonts
Medical · Winston Salem, NCNPI 1528121654
Payments from drug & device makers
Across 166 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$545
- AstraZeneca$378
- GSK$316
- Regeneron Healthcare Solutions, Inc.$277
- Gilead$186
- Mallinckrodt Hospital Products Inc.$166
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,13397%
- Education$983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 24 | $545 |
| AstraZeneca | 19 | $378 |
| GSK | 22 | $316 |
| Regeneron Healthcare Solutions, Inc. | 10 | $277 |
| Gilead | 10 | $186 |
| Mallinckrodt Hospital Products Inc. | 8 | $166 |
| Baxter Healthcare | 7 | $145 |
| United Therapeutics Corporation | 7 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $132 |
| Actelion Pharmaceuticals US, Inc. | 5 | $116 |
| Merck | 7 | $109 |
| Mylan Specialty L.p. | 5 | $88 |
| Vifor Pharma, Inc. | 2 | $61 |
| Sanofi | 2 | $59 |
| Insmed, Inc. | 3 | $58 |
| Novartis | 2 | $42 |
| Philips North America LLC | 3 | $41 |
| Advanced Respiratory, Inc | 2 | $41 |
| Tactile Systems Technology Inc | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| La Jolla Pharmaceutical Company | 2 | $33 |
| Pfizer | 2 | $32 |
| Shionogi Inc | 2 | $30 |
| Electromed, Inc. | 2 | $27 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| BD | 1 | $19 |
| Bard Peripheral Vascular, Inc. | 1 | $19 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
| Covis Pharma GmbH | 1 | $12 |
| Phadia US Inc. | 1 | $12 |
How this compares
$3,232 in reported general payments places this provider in the 80th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 238 | $196,008 |
| Breo ElliptaFluticasone/Vilanterol | 100 | $45,413 |
| Spiriva RespimatTiotropium Bromide | 66 | $40,719 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 39 | $20,449 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $17,027 |
| SymbicortBudesonide/Formoterol Fumarate | 56 | $16,699 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $10,832 |
| Spiriva HandihalerTiotropium Bromide | 13 | $6,746 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $5,412 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 19 | $5,166 |
| Arnuity ElliptaFluticasone Furoate | 22 | $4,865 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 196 | $4,785 |
| Wixela InhubFluticasone Propion/Salmeterol | 24 | $3,978 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $3,555 |
| Qvar RedihalerBeclomethasone Dipropionate | 17 | $3,479 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $316 | $257,119384 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $545 | $61,167105 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $378 | $33,72784 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $34 | $3,47917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 878 medical providers in North Carolina.
Other medical in Winston Salem
- Amanda ZimmermanWinston Salem$48K
- John RobbinsWinston Salem$26K
- Christopher GeorgeffWinston Salem$13K
- Victoria HinkelWinston Salem$12K
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- David TaylorMorehead City$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.